Ofloxacin Otic Solution Rx
Generic Name and Formulations:
Various generic manufacturers
Indications for Ofloxacin Otic Solution:
Otitis externa in adults and children. Chronic suppurative otitis media in adults with perforated tympanic membrane. Acute otitis media in children with tympanostomy tubes.
Adults and Children:
<6mos: not established. Otitis externa: 6mos–13yrs: 5 drops in affected ear(s) once daily. ≥13yrs: 10 drops in affected ear(s) once daily. Both: treat for 7 days. Acute otitis media: 1–12yrs: 5 drops in affected ear(s) twice daily for 10 days. Chronic suppurative otitis media: ≥12yrs: 10 drops in affected ear(s) twice daily for 14 days.
Discontinue if hypersensitivity reaction occurs. Reevaluate if no improvement after 1 week. Pregnancy (Cat.C). Nursing mothers: not recommended.
Pruritus, taste perversion, local reactions, dizziness, earache, headache, vertigo, superinfection, paresthesia, rash.
Formerly known under the brand name Floxin Otic.
Clinical Pain Advisor Articles
- FDA Takes Steps to Reconcile Needs of Patients With Chronic Pain, Efforts to Curb Opioid Epidemic
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Stat Consult: Chronic Low Back Pain
- Opioid Misuse May Help Predict Alcohol Dependence Treatment Outcomes
- Neuropathic Symptoms Worsen Quality of Life, Function in Hip, Knee Osteoarthritis
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- Switching From Buprenorphine-Naltrexone to XR-Naltrexone as Effective as XR-Naltrexone
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Human Diagnosis Project Aims to Address Challenges Among Uninsured
- Healthcare Technology Affects Younger Patient Satisfaction
- FDA Announces New Drug Shortages Task Force